Management Team   BOD   SAB   CAB   About Metabolic Diseases
  Home > About > Board of Directors > Investors  
Metabolex is privately held. We are supported by investors who have invested an aggregate of $117 million since August 2003. Our major investors include:
Alta Partners KBC Funds
Alliance Bernstein MPM BioEquities
Bay City Capital Merlin Biomed Group
Birchmere Ventures Novo Ventures
Biotech Turnaround Fund BV Pictet Funds (LUX)
Charter Life Sciences T. Rowe Price
Deerfield Management VantagePoint Ventures
Johnson & Johnson Development Corporation Venrock Partners
Lombard Odier Darier Hentsch Versant Ventures